"We get approached all of the time by companies who want us to re-sell their products, and we reject nearly every one of them because they don't meet our very rigorous standards," said Michael Saiber, founder and CEO of E3Live. "I heard about what Eversea was offering and tried it, as I had never come across a USDA certified organic, plant-based omega-3 DHA product. Immediately, my body recognized it as an important and necessary addition to my diet. I believe our customers will be very interested in this product as well. The best testimonial about Eversea's powder that I can give is that I take it every single day."
This initial agreement is for Nanuq TM omega-3 DHA powder, which complements E3Live's A phanizomenon flos-aquae (AFA), a nutrient-dense aqua-botanical (blue-green algae). E3Live has amassed a list of dedicated customers over the last 27 years in the certified organic nutritional algae business.
"Given E3Live's stature in the organic industry when it comes to algae-based superfoods, this partnership is an exciting endorsement for our organic omega-3 DHA product," said Gerri Greenham, CEO of Solarvest. "Both companies are very committed to providing the highest quality algae products in the world, and being able to offer E3Live customers our algae and algae-based products is a perfect fit and ideal opportunity."
About E3Live
Widely regarded as one of the organic industry's premier superfood brands, E3Live has been selling organic health products and aqua-botanicals since 1995. The company's signature superfoods, E3Live and BrainON, are both nutrient-dense aqua-botanical nutritional algae harvested from the pristine waters of Klamath Lake in Oregon. E3Live employs the highest quality harvesting methods, safety standards, and purity testing, in addition to adhering to strict Good Manufacturing Practices (GMPs) in order to maintain USDA organic certification and Kosher certification.
About Eversea
Eversea has developed the world's first organic omega-3 DHA from algae. It is both USDA and EU certified organic, and it has received Glyphosate Residue Free certification from The Detox Project. The product is also vegan, gluten-free, free from major allergens, and tested for heavy metals and other contaminants. The omega-3 active ingredient in the products is patented and patent-pending
in commercially relevant/important countries globally. The patent has already been issued in Australia, India, and Japan, and the Solarvest patent also covers the production of EPA.
The company's organic algal-based products have natural advantages over fish oil, which is processed from dwindling sea harvests. Eversea's products are based on marine microalgae and their ability to produce high levels of long-chain omega-3 fatty acid oil, primarily docosahexaenoic acid (DHA). Algae production is sustainable, and sustainability is a growing concern for the market.
About Solarvest
Solarvest BioEnergy Inc. is an algae biologics company whose production platform provides an extremely flexible system capable of producing numerous products from omega-3 fatty acids to human therapeutic proteins. The company has successfully demonstrated the expression of high-value therapeutic proteins, viral antigens (immune-stimulating proteins), and Cecropins (antimicrobial peptide/protein). The company has initiated a program for the expression of CBD and THC to be produced in GMP fermentation facilities.
For further information contact:
Gerri Greenham, Chief Executive Officer
Phone: (647) 204-4095
Email: invest@solarvest.ca
Forward-Looking Information
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the terms of the Offering, the completion of the Offering and the expected use of the net proceeds received by the Company. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: general business, economic, competitive, geopolitical and social uncertainties; and regulatory risks. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information contained in this news release is expressly qualified in its entirety by this cautionary statement. The Company does not undertake to update any forward-looking information, except as required by applicable securities laws.
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
None of the securities of Solarvest have been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law, and may not be offered or sold in the United States or to, or for the account or benefit of, persons in the United States or "U.S. persons" (as such term is defined in Regulation S under the U.S. Securities Act) absent registration or an exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy in the United States nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.
Copyright (c) 2022 TheNewswire - All rights reserved.
